NTRA
Price
$401.37
Change
-$12.01 (-2.91%)
Updated
Oct 22 closing price
Capitalization
57.86B
13 days until earnings call
Intraday BUY SELL Signals
NXGL
Price
$4.76
Change
-$0.52 (-9.85%)
Updated
Oct 22 closing price
Capitalization
46.4M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NTRA vs NXGL

NTRA vs NXGL Comparison Chart in %
View a ticker or compare two or three
VS
NTRA vs. NXGL commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Hold and NXGL is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NTRA with price predictions
Oct 22, 2026

NTRA's Stochastic Oscillator driving into overbought zone

The Stochastic Oscillator for NTRA moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NTRA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 25 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.

The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

NTRA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NTRA as a result. In 82 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

Following a +3.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in 245 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 228 of 286 cases where NTRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (31.762) is normal, around the industry mean (66.046). NTRA's P/E Ratio (-297.311) is considerably lower than the industry average of (2.422). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (17.857) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for NXGL with price predictions
Oct 22, 2026

NXGL's RSI Oscillator ascends from oversold territory

The RSI Oscillator for NXGL moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 24 of the 27 cases the stock moved higher. This puts the odds of a move higher at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 73 cases where NXGL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on NXGL as a result. In 100 of 116 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for NXGL just turned positive on October 09, 2026. Looking at past instances where NXGL's MACD turned positive, the stock continued to rise in 47 of 54 cases over the following month. The odds of a continued upward trend are 87%.

Following a +11.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where NXGL advanced for three days, in 148 of 186 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXGL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

NXGL broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NXGL entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.375) is normal, around the industry mean (4.961). P/E Ratio (-6.432) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.172) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. NXGL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
NTRA: Fundamental Ratings
NTRA
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTRANXGL
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
58%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (NTRA: $401.37 vs. NXGL: $4.76)
Brand notoriety: NTRA and NXGL are both not notable
NTRA represents the Medical Specialties, while NXGL is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NTRA: 118% vs. NXGL: 36%
Market capitalization -- NTRA: $57.86B vs. NXGL: $46.4M
NTRA [@Medical Specialties] is valued at $57.86B. NXGL’s [@Pharmaceuticals: Other] market capitalization is $46.4M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Medical Specialties] industry is $21.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 2 FA rating(s) are green while NXGL’s FA Score has 1 green FA rating(s).

  • NTRA’s FA Score: 2 green, 3 red.
  • NXGL’s FA Score: 1 green, 4 red.
According to our system of comparison, NTRA is a better buy in the long-term than NXGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 3 TA indicator(s) are bullish while NXGL’s TA Score has 5 bullish TA indicator(s).

  • NTRA’s TA Score: 3 bullish, 5 bearish.
  • NXGL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NXGL is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а -0.84% price change this week, while NXGL (@Pharmaceuticals: Other) price change was -8.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.29%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +42.53%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.

Reported Earning Dates

NTRA is expected to report earnings on Nov 05, 2026.

NXGL is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Medical Specialties (-3.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.59% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
NTRA
Daily Signal:
Gain/Loss:
NXGL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NTRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ADPT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
-2.91%
ADPT - NTRA
55%
Loosely correlated
-3.63%
NEO - NTRA
54%
Loosely correlated
-3.81%
GH - NTRA
54%
Loosely correlated
-2.23%
ISRG - NTRA
53%
Loosely correlated
+3.67%
TMO - NTRA
48%
Loosely correlated
-2.52%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PERI8.750.01
+0.11%
Perion Network Ltd
IMA4.05-0.04
-0.98%
ImageneBio Inc
DINT27.18-0.36
-1.31%
Davis Select International ETF (DINT)
AIS59.25-5.14
-7.98%
VistaShares Artificial Intelligence Supercycle ETF
PDFS39.47-4.54
-10.32%
PDF Solutions